Aligos Therapeutics (ALGS) Other Working Capital Changes (2021 - 2025)
Aligos Therapeutics filings provide 5 years of Other Working Capital Changes readings, the most recent being -$113000.0 for Q4 2025.
- On a quarterly basis, Other Working Capital Changes rose 94.43% to -$113000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$96000.0, a 96.42% increase, with the full-year FY2025 number at -$96000.0, up 96.42% from a year prior.
- Other Working Capital Changes hit -$113000.0 in Q4 2025 for Aligos Therapeutics, up from -$411000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $12.4 million in Q2 2022 to a low of -$10.1 million in Q3 2022.
- Median Other Working Capital Changes over the past 5 years was -$389000.0 (2021), compared with a mean of -$569300.0.
- The widest YoY moves for Other Working Capital Changes: up 993.28% in 2022, down 297.8% in 2022.
- Aligos Therapeutics' Other Working Capital Changes stood at -$367000.0 in 2021, then tumbled by 32.15% to -$485000.0 in 2022, then skyrocketed by 314.43% to $1.0 million in 2023, then plummeted by 294.9% to -$2.0 million in 2024, then soared by 94.43% to -$113000.0 in 2025.
- The last three reported values for Other Working Capital Changes were -$113000.0 (Q4 2025), -$411000.0 (Q3 2025), and $579000.0 (Q2 2025) per Business Quant data.